Radiation management of bilateral retinoblastoma: Theneed to preservation

James D. Gagnon, Carrie M. Ware, William T. Moss, Kenneth Stevens

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Thirty-four patients with retinoblastoma were treated in the Radiation Therapy Department of the University of Oregon Health Sciences Center from 1944 to 1978. Twenty-five of these patients had bilateral disease. Most patients were treated with megavoltage equipment and received doses of 5000 rad in 5 weeks. According to the lifetable method, five year survival was 67.6 % ; it increased to 85.7 % if patients who were treated with orthovoltage equipment were excluded. Seventy-one percent of evaluable patients had useful vision at 5 years; an additional two patients had useful vision for two years after radiation therapy. The value of even limited vision during this critical time of sensorimotor and psychological development is discussed. Orthovoltage equipment should not be used to irradiate patients with retinoblastoma.

Original languageEnglish (US)
Pages (from-to)669-673
Number of pages5
JournalInternational journal of radiation oncology, biology, physics
Volume6
Issue number6
DOIs
StatePublished - 1980

Fingerprint

Retinoblastoma
Radiation
radiation
Equipment and Supplies
radiation therapy
Radiotherapy
health
Psychology
dosage
Survival
Health

Keywords

  • Bilateral retinoblastoma
  • Heredity
  • Second tumors
  • Vision preservation

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Radiation management of bilateral retinoblastoma : Theneed to preservation. / Gagnon, James D.; Ware, Carrie M.; Moss, William T.; Stevens, Kenneth.

In: International journal of radiation oncology, biology, physics, Vol. 6, No. 6, 1980, p. 669-673.

Research output: Contribution to journalArticle

Gagnon, James D. ; Ware, Carrie M. ; Moss, William T. ; Stevens, Kenneth. / Radiation management of bilateral retinoblastoma : Theneed to preservation. In: International journal of radiation oncology, biology, physics. 1980 ; Vol. 6, No. 6. pp. 669-673.
@article{b9c63ae087634956941d87afc8773b5b,
title = "Radiation management of bilateral retinoblastoma: Theneed to preservation",
abstract = "Thirty-four patients with retinoblastoma were treated in the Radiation Therapy Department of the University of Oregon Health Sciences Center from 1944 to 1978. Twenty-five of these patients had bilateral disease. Most patients were treated with megavoltage equipment and received doses of 5000 rad in 5 weeks. According to the lifetable method, five year survival was 67.6 {\%} ; it increased to 85.7 {\%} if patients who were treated with orthovoltage equipment were excluded. Seventy-one percent of evaluable patients had useful vision at 5 years; an additional two patients had useful vision for two years after radiation therapy. The value of even limited vision during this critical time of sensorimotor and psychological development is discussed. Orthovoltage equipment should not be used to irradiate patients with retinoblastoma.",
keywords = "Bilateral retinoblastoma, Heredity, Second tumors, Vision preservation",
author = "Gagnon, {James D.} and Ware, {Carrie M.} and Moss, {William T.} and Kenneth Stevens",
year = "1980",
doi = "10.1016/0360-3016(80)90221-7",
language = "English (US)",
volume = "6",
pages = "669--673",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Radiation management of bilateral retinoblastoma

T2 - Theneed to preservation

AU - Gagnon, James D.

AU - Ware, Carrie M.

AU - Moss, William T.

AU - Stevens, Kenneth

PY - 1980

Y1 - 1980

N2 - Thirty-four patients with retinoblastoma were treated in the Radiation Therapy Department of the University of Oregon Health Sciences Center from 1944 to 1978. Twenty-five of these patients had bilateral disease. Most patients were treated with megavoltage equipment and received doses of 5000 rad in 5 weeks. According to the lifetable method, five year survival was 67.6 % ; it increased to 85.7 % if patients who were treated with orthovoltage equipment were excluded. Seventy-one percent of evaluable patients had useful vision at 5 years; an additional two patients had useful vision for two years after radiation therapy. The value of even limited vision during this critical time of sensorimotor and psychological development is discussed. Orthovoltage equipment should not be used to irradiate patients with retinoblastoma.

AB - Thirty-four patients with retinoblastoma were treated in the Radiation Therapy Department of the University of Oregon Health Sciences Center from 1944 to 1978. Twenty-five of these patients had bilateral disease. Most patients were treated with megavoltage equipment and received doses of 5000 rad in 5 weeks. According to the lifetable method, five year survival was 67.6 % ; it increased to 85.7 % if patients who were treated with orthovoltage equipment were excluded. Seventy-one percent of evaluable patients had useful vision at 5 years; an additional two patients had useful vision for two years after radiation therapy. The value of even limited vision during this critical time of sensorimotor and psychological development is discussed. Orthovoltage equipment should not be used to irradiate patients with retinoblastoma.

KW - Bilateral retinoblastoma

KW - Heredity

KW - Second tumors

KW - Vision preservation

UR - http://www.scopus.com/inward/record.url?scp=0018836678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018836678&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(80)90221-7

DO - 10.1016/0360-3016(80)90221-7

M3 - Article

C2 - 7451271

AN - SCOPUS:0018836678

VL - 6

SP - 669

EP - 673

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 6

ER -